Name | Number of supported studies | Average coverage | |
---|---|---|---|
goblet cell | 7 studies | 43% ± 14% | |
enteroendocrine cell | 3 studies | 19% ± 4% |
Insufficient scRNA-seq data for expression of FOXA3 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
liver | 100% | 2362.35 | 226 / 226 | 93% | 75.22 | 378 / 406 |
pancreas | 100% | 1839.97 | 328 / 328 | 92% | 63.48 | 163 / 178 |
stomach | 82% | 1697.53 | 295 / 359 | 95% | 53.09 | 272 / 286 |
intestine | 63% | 575.53 | 604 / 966 | 96% | 62.90 | 508 / 527 |
kidney | 96% | 128.33 | 85 / 89 | 6% | 0.69 | 53 / 901 |
prostate | 69% | 44.51 | 169 / 245 | 8% | 0.82 | 40 / 502 |
lung | 28% | 14.24 | 164 / 578 | 37% | 11.65 | 432 / 1155 |
esophagus | 6% | 4.74 | 88 / 1445 | 48% | 26.77 | 87 / 183 |
bladder | 5% | 1.33 | 1 / 21 | 32% | 16.87 | 159 / 504 |
uterus | 11% | 3.79 | 18 / 170 | 24% | 8.44 | 112 / 459 |
ovary | 3% | 1.02 | 6 / 180 | 22% | 2.77 | 96 / 430 |
peripheral blood | 20% | 38.34 | 182 / 929 | 0% | 0 | 0 / 0 |
breast | 7% | 4.48 | 30 / 459 | 9% | 1.53 | 99 / 1118 |
skin | 1% | 0.37 | 15 / 1809 | 5% | 0.55 | 24 / 472 |
tonsil | 0% | 0 | 0 / 0 | 4% | 0.62 | 2 / 45 |
thymus | 3% | 1.02 | 22 / 653 | 0% | 0.05 | 3 / 605 |
lymph node | 0% | 0 | 0 / 0 | 3% | 0.33 | 1 / 29 |
spleen | 3% | 2.48 | 7 / 241 | 0% | 0 | 0 / 0 |
adipose | 3% | 1.95 | 32 / 1204 | 0% | 0 | 0 / 0 |
muscle | 2% | 0.99 | 19 / 803 | 0% | 0 | 0 / 0 |
brain | 1% | 0.38 | 28 / 2642 | 0% | 0.03 | 3 / 705 |
adrenal gland | 0% | 0 | 0 / 258 | 1% | 0.23 | 2 / 230 |
heart | 1% | 0.23 | 6 / 861 | 0% | 0 | 0 / 0 |
blood vessel | 1% | 0.38 | 8 / 1335 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0006325 | Biological process | chromatin organization |
GO_0006366 | Biological process | transcription by RNA polymerase II |
GO_0007283 | Biological process | spermatogenesis |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0009267 | Biological process | cellular response to starvation |
GO_0001678 | Biological process | intracellular glucose homeostasis |
GO_0061484 | Biological process | hematopoietic stem cell homeostasis |
GO_0030154 | Biological process | cell differentiation |
GO_0009653 | Biological process | anatomical structure morphogenesis |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0005654 | Cellular component | nucleoplasm |
GO_0015629 | Cellular component | actin cytoskeleton |
GO_0000785 | Cellular component | chromatin |
GO_0005634 | Cellular component | nucleus |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_0019904 | Molecular function | protein domain specific binding |
GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
GO_0000976 | Molecular function | transcription cis-regulatory region binding |
GO_1990837 | Molecular function | sequence-specific double-stranded DNA binding |
GO_0003700 | Molecular function | DNA-binding transcription factor activity |
GO_0005515 | Molecular function | protein binding |
Gene name | FOXA3 |
Protein name | Hepatocyte nuclear factor 3-gamma (HNF-3-gamma) (HNF-3G) (Fork head-related protein FKH H3) (Forkhead box protein A3) (Transcription factor 3G) (TCF-3G) Forkhead box A3 |
Synonyms | HNF3G TCF3G |
Description | FUNCTION: Transcription factor that is thought to act as a 'pioneer' factor opening the compacted chromatin for other proteins through interactions with nucleosomal core histones and thereby replacing linker histones at target enhancer and/or promoter sites (By similarity). Originally described as a transcription activator for a number of liver genes such as AFP, albumin, tyrosine aminotransferase, PEPCK, etc. Interacts with the cis-acting regulatory regions of these genes. Involved in glucose homeostasis; binds to and activates transcription from the G6PC1 promoter. Binds to the CYP3A4 promoter and activates its transcription in cooperation with CEBPA. Binds to the CYP3A7 promoter together with members of the CTF/NF-I family. Involved in regulation of neuronal-specific transcription. May be involved in regulation of spermatogenesis. . |
Accessions | M0QZW5 ENST00000302177.3 ENST00000594297.1 P55318 |